Clinical trials
Recruiting Observational Ovarian Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
117 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 1 |
| 2003 | 2 |
| 2004 | 1 |
| 2006 | 1 |
| 2009 | 1 |
| 2012 | 1 |
| 2013 | 4 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 4 |
| 2021 | 9 |
| 2022 | 17 |
| 2023 | 11 |
| 2024 | 22 |
| 2025 | 21 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 117 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 9 |
| Fudan University | 3 |
| University Health Network, Toronto | 3 |
| AbbVie | 2 |
| AstraZeneca | 2 |
| Azienda USL Reggio Emilia - IRCCS | 2 |
| Centro di Riferimento Oncologico - Aviano | 2 |
| Hospices Civils de Lyon | 2 |
| IRCCS Azienda Ospedaliero-Universitaria di Bologna | 2 |
| Institut Paoli-Calmettes | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ovarian Neoplasms | 117 |
| Breast Neoplasms | 24 |
| Endometrial Neoplasms | 22 |
| Lung Neoplasms | 19 |
| Uterine Cervical Neoplasms | 18 |
| Neoplasms | 16 |
| Colorectal Neoplasms | 14 |
| Pancreatic Neoplasms | 14 |
| Prostatic Neoplasms | 11 |
| Melanoma | 10 |
Trials
Showing 1 to 25 of 117. Each trial links to its page on Pharma Observatory.
17 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.